COR2ED - Rare Diseases Medical Conversation

Think Narcolepsy: Why Early Recognition and Referral Matter

Listen Later

Join experts Dr Markus Schmidt and Dr Anna Heidbreder as they discuss the importance of early recognition and referral in narcolepsy type 1 (NT1), particularly as new targeted treatments begin to emerge. 

Key discussion points include: 

  • Emerging therapies: How OX2R agonists may transform narcolepsy care, with Phase 3 overporextin data showing significant improvements in wakefulness and cataplexy with no serious AEs reported. 
  • Diagnostic red flags: Recognising excessive daytime sleepiness, cataplexy, sleep paralysis, and hallucinations to help reduce the current 7–10 year delay in diagnosis. 
  • Clinical pitfalls: Avoiding common misdiagnoses, such as attributing symptoms to lifestyle-related fatigue in younger patients or sleep apnoea in older adults. 
  • Specialist referral: The importance of timely referral for specialist assessment and objective sleep testing to support earlier access to emerging therapies. 

    • By identifying these symptom clusters earlier, clinicians may improve long-term outcomes and quality of life for people living with NT1. 

     

    Key clinical takeaways:  

    • New treatment options are emerging: OX2R agonists represent a shift toward targeting the underlying biology of NT1, with the potential to significantly improve patient outcomes 
    • Early recognition is critical: Narcolepsy is often under-recognised and misdiagnosed, so clinicians should maintain a high index of suspicion, particularly in patients with excessive daytime sleepiness 
    • Act early and refer appropriately: Timely referral to specialists is essential to confirm diagnosis, optimise management, and ensure patients can benefit from current and emerging therapies 

      • You can also watch a video of the experts in conversation and download the accompanying transcript on our website: https://cor2ed.com/sleep-connect/programmes/narcolepsy-early-recognition-referral/?media=0 

      Or watch on YouTube: https://youtu.be/jHgORhjB_lw 

      Follow us on social media: 

      LinkedIn: https://www.linkedin.com/company/sleep-connect/about/ 

      X: https://x.com/SleepConnect_  

      Instagram: https://www.instagram.com/cor2edmeded  

       

      This content is intended for healthcare professionals only. 

      This podcast is supported by an Independent Education Grant from Takeda  

       

      This podcast is developed by cor2ed.com 

      Published May 2026 

       

      Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released. 

      ...more
      View all episodesView all episodes
      Download on the App Store
      COR2ED - Rare Diseases Medical ConversationBy COR2ED Medical Education